Bailong Chuangyuan(605016) 证券之星·2025-03-28 12:21Core Viewpoint - The legal opinion confirms that the procedures for convening and holding the 2025 First Extraordinary General Meeting of Shandong Bailong Chuangyuan Biotechnology Co., Ltd. comply with relevant laws and regulations, ensuring the validity of the meeting and its resolutions [2][8]. Group 1: Meeting Procedures - The meeting was convened on March 28, 2025, following a resolution passed by the board of directors on March 12, 2025 [2][3]. - The meeting utilized a combination of on-site and online voting methods, with specific time slots designated for each voting method [4][6]. - The meeting was presided over by the company's chairman, Dou Baode, and was attended by a total of 130 shareholders and their representatives, representing 164,271,094 shares, which is 50.8443% of the total shares [4][5]. Group 2: Attendance and Voting - The attendance included 7 shareholders at the on-site meeting, representing 163,589,179 shares (50.6333%), while 123 shareholders participated via online voting [5]. - The meeting's resolutions were voted on, with the results being counted and announced immediately [6][7]. - The voting results showed overwhelming support for the proposed resolutions, with 99.9725% of the votes in favor [6][8]. Group 3: Legal Compliance - The legal opinion asserts that all aspects of the meeting, including the qualifications of attendees and the procedures followed, were in accordance with the Company Law and the Articles of Association [2][8]. - The resolutions passed during the meeting were deemed legally valid and effective [8].